Real-time enrollment status for this secondary immune deficiency clinical trial
Current Status
Recruiting
Checked: September 9, 2026 at 9:54 PM UTC
| NCT Number | NCT07648264 |
| Recruiting Status | Recruiting |
| Condition | Secondary Immune Deficiency |
| Phase | PHASE3 |
| Target Enrollment | 63 participants |
| Active Locations | 17 sites in the US |
| Sponsor | CSL Behring |
| Last Updated on CT.gov | September 9, 2026 (21 hours ago) |
As of September 9, 2026: Clinical trial NCT07648264 is currently recruiting participants. This phase3 study for secondary immune deficiency is actively seeking new participants at 17 locations across the United States. The study is sponsored by CSL Behring. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07648264 is actively recruiting participants as of September 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07648264 was last updated 21 hours ago (September 9, 2026). HelloStudys verifies this status automatically.